We qualitatively assessed attitudes regarding use of hypertonic saline nasal irrigation (HSNI) for frequent rhinosinusitis and chronic sinonasal symptoms in a 3-part, multimethod study.
INTRODUCTION

R hinosinusitis
1 is a common clinical problem with considerable morbidity and often-refractory symptoms, accounting for approximately 26.7 million offi ce and emergency department visits and resulting in $5.8 billion in direct costs for 1996. 2 Rhinosinusitis was the fi fth most common diagnosis for which antibiotics were prescribed from 1985 to 1992. 3 The Centers for Disease Control and Prevention has estimated the 1994 number of cases of chronic rhinosinusitis in the United States to be 35 million, a prevalence of 134/1,000. 4 The impact on patients' quality of life is signifi cant. 5 Originally part of the Yogic and Ayurvedic traditions, hypertonic saline nasal irrigation (HSNI) is an adjunctive therapy for rhinosinusitis and sinus symptoms [6] [7] [8] that fl ushes the nasal cavity, facilitating the evacuation of potentially allergen-and irritant-containing mucus 9 ( Figure 1 ). Several randomized controlled trials examining HSNI suggest that it is a safe, effective, and tolerable therapy for rhinosinusitis and sinus symptoms. [10] [11] [12] [13] [14] [15] [16] [17] Previous randomized controlled trials have reported improvement of quality-of-life scores, [10] [11] [12] 17 and improvement of several surrogate measures. [12] [13] [14] 17 In a closely monitored 6-month randomized controlled trial (phase 1, Figure 2 ), 17 our group found that daily HSNI using 2% saline is associated with high patient satisfaction, improved quality of life, decreased antibiotic and nasal spray use, and improved sinus symptoms in adult participants with a history of frequent rhinosinusitis and chronic sinus complaints. In a 12-month follow-up study (phase 2), 18 we found that patient education without close monitoring enabled phase 1 control participants to initiate and maintain identical HSNI use patterns, and that control participants had the same signifi cant and clinically meaningful improvements in quality of life. HSNI has received attention in the lay press 19 and was recently identifi ed as "an important component in the management of most sinonasal conditions" that is "effective and underutilized." 20 Successful use of even proven therapy is often difficult for patients, however. 21 Clinicians may be hesitant to prescribe unfamiliar therapy, and misunderstandings between clinician and patient often occur. 22 HSNI is associated with diffi cult adherence issues because rinsing the nasal cavity is not intuitive. Clinicians and patients would be well served by descriptive information of successful HSNI use, but no study has assessed the natural history of long-term use of HSNI and its incorporation into daily life. We therefore undertook a qualitative study (phase 3) to assess perceptions, experiences, and strategies regarding successful HSNI use at the conclusion of phases 1 and 2.
METHODS
The study protocol was approved by the University of Wisconsin Health Sciences Human Subjects Committee. The inclusion criterion was being an HSNI-user in either the phase 1 randomized controlled trial or the phase 2 follow-up study (Figure 2 ). The primary inclusion criteria of phase 1 was having either 2 episodes of acute sinusitis or 1 episode of chronic sinusitis per year for 2 consecutive years, and a moderate-to-severe overall daily quality-of-life burden of sinus disease. Participants randomized to HSNI in phase 1 received an educational intervention that included a brief discussion of rhinosinusitis, a demonstration of HSNI, and coaching to facilitate each participant's profi ciency. All participants in phase 1 were monitored frequently with validated questionnaires. 23 In phase 2, phase 1 control participants were given the same patient-education and pooled into 1 HSNI use group. All phase 2 participants were thereafter assessed less frequently. The mean HSNI use frequency at the time of the interviews was 2.4 irrigations per week after at least 12 months of assessment. 18 For the current study, we contacted phase 1 and phase 2 HSNI users sequentially from a randomized list of all 66 possible participants ( Figure 2 ). Study personnel tape-recorded interviews of 21 participants in person and 7 participants by telephone at our institution from April to July 2002. We followed a standard qualitative research method of transcribed, in-depth, long interviews. 24 The semistructured 30-minute interview consisted of open-ended questions with several prompts that the interviewer could use to encourage salient discussion (Table 1) . Transcripts were stripped of all identifi ers except a code number. All interviews were completed and transcribed before being analyzed. Each transcript was reviewed individually by each of the fi rst 4 authors and was then discussed by all of the fi rst 4 authors in 6 meetings over 2 months using a consensus approach to identify major themes.
RESULTS
Consent from 28 participants was obtained from the fi rst 35 HSNI users queried; 7 participants declined to participate, stating they did not have time, resulting in a 28-member sample similar to the 66 HSNI users in phases 1 and 2 in sex, age, and quality-of-life scores at the beginning and end of the studies. One participant had completed phase 1 only, 27 had completed both phases 1 and 2 ( Table 2 ). The 28 transcribed interviews were analyzed in 6 meetings. Four major themes emerged (Table 3) .
Major Themes Empowerment
Among the major themes, participants reported several ways in which use of HSNI improved their ability to control sinus symptoms and their treatment, a major aspect of their health and health care. We have termed this empowerment. Participants expressed a strong sense of satisfaction with the ability to use, monitor, and adjust several aspects of HSNI themselves (eg, water temperature, salinity, timing, frequency) as opposed to making multiple offi ce visits with a clinician. This attitude was commonly refl ected in such comments as, 
Improvement in Quality of Life
Participants confi rmed the results of phases 1 and 2; use of HSNI improved short-and long-term sinus symptoms and sinus-related quality of life. Many participants were enthusiastic, reporting improvements with the fi rst or second use: "… my results were immediate," and "… almost instant relief of the congestion." Most participants also confi rmed positive long-term effects of HSNI on sinus-related quality of life, and noted a deep sense of satisfaction associated with the diminution of their sinus symptoms, often refl ected in moving comments, such as, " It just made a world of difference in my life," and "… when you suffer from a chronic illness for so long and then you don't, … it's such a big relief … (to) enjoy things that people take for granted." Participants (12 mo) also expressed satisfaction with a perceived association with decreased allergy symptoms and with the naturalness and economy of HSNI.
Barriers to HSNI Use
While HSNI was effective for many participants, many also reported substantial barriers to initial and consistent use of HSNI. These barriers included fear of having water in the nasal cavity, initial unpleasant sensation of water in the nasal cavity, having to learn how to perform HSNI effectively, taking time at home to do HSNI, and experiencing occasional mild side effects. Consistent with phases 1 and 2, such side effects as saline drainage, nasal burning, or irritation were noted but not identifi ed as important enough to stop HSNI.
Strategies to Overcome Barriers to HSNI Use
Participants identifi ed how they overcame barriers to using HSNI. Participants identifi ed each element of the teaching strategy used in the introductory meeting as important in their use of HSNI. These 30-minute meetings were made up of 2 to 6 participants per meeting; they involved a sequence of activities starting with a group discussion of participants' sinus disease histories, a 5-minute fi lm and discussion of nasal irrigation, and a demonstration and coached practice of HSNI. Participants identifi ed coached practice as the single most important element of the enrollment meeting. Each participant was able to perform the procedure before leaving the enrollment meeting.
Participants also noted several at-home strategies that facilitated regular use, which included incorporating HSNI into an already-existing daily hygiene routine, placing HSNI materials in convenient and accessible locations, adjusting the HSNI use schedule and salinity to decrease or eliminate discomfort, and using warm water. Social concerns were also addressed by our interviewers. Because HSNI therapy is novel for most patients and could engender stigma or embarrassment, we wondered whether social issues played a part in the tendency to regular use. Participants reported reactions from family and friends that included encouragement, surprise, or amusement; none reported that negative reactions from family or friends limited their use of HSNI.
The themes and quotations illustrate participants' range of experience. The overall story of using HSNI, however, may be better told using an extended quotation. An abbreviated transcript of a representative participant whose narrative provides a more personal view of the major themes can be found in Table 3 . Her reporting was neither especially negative about the initial aspects of nasal irrigation nor overly effusive about her success. It is consistent with the data from this group of participants who had a debilitating condition (chronic sinus symptoms), who were introduced to a nonintuitive therapy, the mastery of which required work and insight (performing HSNI), and who achieved therapeutic success (improved quality of life). Her transcript identifi ed the core themes in a matter-offact manner. Bracketed words are the authors' interpretation of the participant's original intent; they are used to link ideas or abbreviate wordiness.
DISCUSSION
This study is the third of a 3-phase study assessing HSNI for frequent rhinosinusitis and chronic sinus complaints. Phases 1 and 2 found that participants in both a fastidious 25 randomized controlled trial 17 and pragmatic follow-up setting 18 experienced improved quality of life, reduced sinus symptoms, and decreased use of sinus medications, including antibiotics. The current study is the fi rst to assess the perceptions, experiences, and strategies surrounding use of HSNI and thereby bridge * Using a 30-item validated multidimensional disease-specifi c assessment instrument, participants scored their sinus symptoms: 0 = maximal impact of sinus symptoms on quality of life, 100 = no impact. † Using a 1-7 Likert scale, where 1 = no impact, and 7 = maximal impact, participants responded to the statement: "Please evaluate the overall severity of your sinus symptoms since enrolled in the study."
Table 3. Major Themes and Representative Narrative Emerging From the Qualitative Survey Theme Descriptive Comments
Empowerment "It's really truly a wonderful opportunity for me to get what I needed health-wise that makes me feel more in control of my own health and my own sinus condition." "What's different is that I don't anymore feel like there's no relief." "It's so simple, whenever you want, you can do it." "I've learned that I can take care of a lot of this by myself, so I do." "You don't have to run to the doctor every few months to get on antibiotics again." "The best thing is not having to go to the doctor. Not having to use antibiotics." Quality of life " … almost instant relief of the congestion.…" "… my results were immediate. I went from being congested to breathing, and I would stay clear all day." "I could actually feel … the pressure-kind of a dam held, and then it whooshed out the other side."
"It just made a world of difference in my life." "For me this is the magic cure for my sinuses."
"Best thing I've ever had. Better than any medication. It's amazing. I would recommend it to anybody."
"When you suffer from a chronic illness for so long and then you don't have problems with it anymore: I think it's such a big relief and I can't explain it, it's such a big change where you can enjoy things that people take for granted." "… the fi rst time that you use it, it's a strange sensation-that feeling of water.…" "… it was kind of strange-kind of like you're drowning, almost …" "Pure and simple: it was gross. It took a while to get used to it. It felt really funky."
"The hardest part was creating a habit of doing it and doing it all the time." "I thought it was not a very graceful thing. Not a very easy thing to do."
Strategies for overcoming barriers
Teaching strategies "It helped to hear that there were other people going through those reactions and stuff, and I didn't realize that I was feeling isolated until I met some of the other people."
"(The part of the fi rst meeting I liked most … was) being around other people that are having trouble with their sinuses."
"It needs to be not just prescribed: It needs to be taught with a video or some type of informational packet with it."
"I think the demonstration that the doctor had with us was the most helpful part."
"The hands-on was critical."
"The actual instruction when we went to the [sink] and you showing us directly how to use it made all the difference in the world."
At-home strategies "I just established a habit."
"I learned to adjust the temperature and salt content to what felt best." "I guess when I was in the shower it was a lot easier." "I don't know if I was more relaxed and the steam or whatever…, but it seemed to be a lot more effective in the shower." "After you do it a few times, it's nothing anymore"
Representative narrative "I spent a lot of time in the doctor's offi ce for sinus infections or being frustrated with sinus symptoms … and [had] frequent sinus headaches-as many as 3-4 per week. [The fi rst time I used HSNI] it felt like warm water running down my nose and some of it into my throat … I did it wrong. My initial thought was 'Oh my God, this is not going to work.' But I did it … when we were coached … and I … worked at it … about 20 minutes in the bathroom that night. When I got it to work, it felt wonderful. I'd say it took a week before I got it down to a fi ne art. The fi rst evening, I could already tell I was cleaning something out.… I was blowing all this junk out of my head. By the third evening, it was clear that there was defi nitely a point to this, less sinus drainage, and that it was going to help me. I also notice that I've been able to smell things [better] . I haven't had a sinus infection in I can't remember how long. the gap between clinical effectiveness of HSNI in formal studies and success with at-home use. We found that participants receiving clear and focused instruction can overcome initial barriers to HSNI use and can create athome strategies to facilitate long-term HSNI use. Effective teaching combined with a positive clinical outcome led to improved quality of life and sense of empowerment for these participants. The introductory meeting set the stage for participants' use of a therapy by establishing a relationship with research staff and trust in the overall research plan. Group discussion of clinical histories promoted an esprit de corps regarding use of HSNI and participation in the study. Group interaction and discussion have been used to facilitate understanding and acceptance of one's condition, and the notion that active involvement in therapy can facilitate improved clinical outcomes. Group discussion also served to decrease the alienation and stress that participants may have felt in isolation. Hearing others' clinical stories likely increased bonds with fellow participants and may have helped participants feel that their own story was heard and valued. Positive effects of group behavior programs have resulted in improved outcomes in other treatment settings. [26] [27] [28] Early demonstration and coached practice of HSNI ensured profi ciency before the participants' fi rst at-home use. Patient education and coached practice have been identifi ed as important aspects of successful care of chronic illness 29 and have been linked to successful treatment of chronic conditions such as asthma and COPD. 30 Given that the immediate effect of HSNI under supervision was generally positive, and side effects were limited, participants were able to adapt the scheduling, location, and materials handling to best suit their personal and social context in the long term. This ability to manage their own treatment likely contributed to the reported sense of empowerment and personal control of their chronic symptoms, further enabling continued use. A sense of empowerment among users of complementary medical therapy is consistent with recent fi ndings that characterize patients' views about complementary medical therapy compared with conventional therapy. 31 Because 3 of us (DR, BB, RM) were co-researchers on phases 1 and 2, we anticipated that the comments would be positive, but several aspects of the results surprised us. First was the passion and drama of many reports. Sinus disease, HSNI, and clinical improvement are clearly important to these participants and deeply affect the quality of their lives. Also surprising was the uniform reporting about 2 issues. First, most participants expressed the need to overcome the oddness of pouring water through the nasal cavity, Second, it was worth the effort of doing so, because HSNI truly improved quality of life for this group of participants, most of whom had had less success with multiple previous therapies.
Our study has several limitations. These results may not generalize well to patients who have uncomplicated acute bacterial rhinosinusitis, less-frequent rhinosinusitis, sinus symptoms that are less chronic, or have undergone less HSNI coaching. Recollection of initial experiences and feelings toward HSNI may have been inaccurate, because participants were interviewed 12 to 18 months after starting phase 1. We did not use an iterative process to guide the formulation of interview questions and may have missed issues important to participants. The researchers may have been biased in favor of HSNI because 3 coauthors were familiar with the positive quantitative HSNI results of phases 1 and 2.
Implications for Clinicians
This study has important implications for clinicians. HSNI can be confi dently and safely prescribed to patients with chronic sinonasal symptoms. Adherence to HSNI will likely be improved by a patient-education encounter that includes coached practice of HSNI. Consideration should be given to grouping several patients into a single class for patient education. In our clinical practice, we describe the rationale for HSNI as part of the treatment plan for patients with chronic sinonasal complaints; if the patient is interested, we explain the technique with an illustrated patient handout, as shown in Supplemental Appendix, which can be found online at http://www.annfammed.org/ cgi/content/full/4/4/295/DC1, and at http://www. fammed.wisc.edu/research/projects/nasalirrigationinstructions.pdf), before we proceed with guided practice. We recommend using nasal irrigation once daily at the onset of sinus symptoms until resolution, and thereafter for maintenance as needed. The materials are inexpensive, and nasal irrigation cups are increasingly available at local pharmacies nationwide.
Implications for Researchers
This study has implications for future HSNI research. Questions remain about the basic science of HSNI, clinical protocol (eg, irrigation schedule, irrigant concentration, buffering, and irrigant delivery system), specifi c indications, and optimal training techniques and context. These issues require study in a larger patient population with more identifi ed subgroups, including acute bacterial rhinosinusitis, vasomotor rhinitis, and asthma.
In addition, the current study also has implications for primary care research. Integrated, multi-method research techniques in primary care have been described and advocated. 32, 33 Taken together with phases 1 and 2, the current study is an example of such an approach. By using both qualitative and quantitative methods, a broader and deeper picture of HSNI use emerges than if either were used alone. Phases 1 and 2 used a conventional, quantitative hypothesis-testing approach that produced internally consistent conclusions; HSNI is an effective therapy for patients with recurrent rhinosinusitis and chronic sinonasal complaints. In phase 3, we asked participants to describe and interpret the experience of HSNI. Such qualitative data brings the use of HSNI closer to real clinical life by making the quantitative fi ndings easier to act upon for physicians and patients.
Participants confi rmed positive results from 2 previous studies. HSNI is an effective, safe, well-tolerated, inexpensive therapy that patients with frequent rhinosinusitis and chronic sinus symptoms can learn in the offi ce and use at home over the long term with minimal training and follow-up. Clinical success with HSNI will likely be improved by brief patient education, HSNI demonstration, in-person coaching, and the ability to tailor HSNI use to individual needs.
